K.J. Mason

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Nick Dand, Michael Duckworth, David Baudry et al. · Journal of Allergy and Clinical Immunology · 2018 · 162 citations · Full text

Autoimmune Disease, Medicine, Biologic Treatment Response +9

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

A formal approach to imperfection in geographic information

Matt Duckham, K.J. Mason, John G. Stell et al. · Computers Environment and Urban Systems · 2001 · 126 citations

Geographic Information Systems, Cartography, Location Information +6

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 114 citations · Full text

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study

Richard B. Warren, Antonia Marsden, Barbara Tomenson et al. · British Journal of Dermatology · 2018 · 105 citations · Full text